SCHEMBL23947425

SCHEMBL23947425

c1ccc(-c2nc(-c3ccc4oc5ccc(-c6ccc7c8ccccc8n(-c8ccccc8)c7c6)cc5c4c3)nc(-c3cccc4oc5ccccc5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
PLA2G10 O15496 1/20 0.34
CHEK2 O96017 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
BACE1 P56817 1/20 0.31
PTGER4 P35408 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
PIM1 P11309 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
PIM3 Q86V86 1/20 0.31
PIM2 Q9P1W9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26168437 0.98 KDM4E (0.37) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23947889 0.97 KDM4E (0.35) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23947427 0.97 KDM4E (0.35) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23558098 0.97 CHEK2 (0.34) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL26168473 0.97 KDM4E (0.36) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL22022418 0.97 KDM4E (0.38) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL21192105 0.97 KDM4E (0.38) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL30483660 0.97 KDM4E (0.38) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL17252941 0.97 KDM4E (0.38) KDM4EATML3MBTL1SIRT2SIRT1
SCHEMBL23557856 0.96 CHEK2 (0.33) KDM4EATML3MBTL1SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 KDM4E 3842/4885ATM 2218/4885L3MBTL1 94/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 KDM4E 3695/4885ATM 2154/4885L3MBTL1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.